Xeltis Reports Positive EU Trial Data for Xabg Graft
July 17, 2025
Preliminary clinical data from Xabg, Xeltis’ coronary artery bypass conduit (CABG), demonstrating positive safety and patency Xeltis, a leading developer of transformative implants that enable